Empowering Pharma, Food & Sustainability Teams to Meet Global Standards

Contact Us

Stay up to date with the latest from across Conscio Group.

Here we share company updates, scientific case studies, white papers, testimonials, and news about our ongoing collaborations, services and conference appearances.

Conscio Group Enters Italy with Acquisition of Studio F2 and Metralab

Conscio Group has entered the Italian market through the acquisition of Studio F2 and Metralab, two ACCREDIA-accredited food testing laboratories

How to Deal with the Matrix Effect as an Unavoidable Phenomenon: A Current Perspective

This white paper reviews the current status of the matrix effect ten years after the original publication. The answer is

Nitrosamine Analogues in APIs and Drug Products: Risk, Testing Strategy, and Practical Pitfalls

Nitrosamine analogues are emerging as a new analytical and quality challenge across APIs and drug products. This expert-led article explores

ADC Performance by Design: From Linker Chemistry to DAR and Bioanalytical Insight

Registration is now open for our free expert-led webinar exploring the chemistry and bioanalytical strategies behind ADC performance.

Two High-Complexity Bioequivalence Studies: Transdermal Gel PK and Intragastric pH Monitoring

Bioequivalence projects are often perceived as “standardized by design.” In practice, however, the most demanding studies are those where execution

Bispecific Antibodies: A New Era in Therapeutic Innovation

Bispecific antibodies (bsAbs) are expanding the boundaries of modern therapeutics. By simultaneously engaging two different targets, these innovative molecules enable

Navigating the EMA Guideline on Equivalence of Topical Products: IVRT/IVPT Study Design

In April 2025, the long-awaited European Medicines Agency (EMA) Guideline on Quality and Equivalence of Locally Applied, Locally Acting Cutaneous

Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

Registration is now open for our free expert-led webinar on streamlined evidence strategies for biosimilar approval, with a special focus

Conscio Group at CPHI 2025 in Frankfurt – Meet Us in Hall 5.1, Stand F1

This October, the global pharmaceutical community will gather in Frankfurt for CPHI 2025. Conscio Group will be there too –

From Analytical Similarity to Clinical Data: Tailoring Evidence for Biosimilar Approval

Registration is now open for our free expert-led webinar on the evolving evidence requirements for biosimilar approval.

The Benefits of FTE Contracts for Pharmaceutical Companies

How can an FTE-based partnership with a CRO transform your pharmaceutical development?

Batch Release Testing and QP Certification: The Backbone of Pharmaceutical Quality Assurance

Are strict pharmaceutical regulations slowing your EU market entry? You're not alone. Navigating the complex landscape of batch release testing

Conscio Group Appoints Gary Chambers as Executive Vice President of Strategy and Marketing

April 3, 2025 – Conscio Group, a leading scientific service provider for the pharmaceutical industry, announces the appointment of Gary

Expediting Biosimilar development: Streamlining the path from research to market

A free webinar on the future of biosimilar pathway to approval is now available for registration

Conscio Group and Kiel Laboratories Announce Strategic Partnership

Conscio Group, a European network of GMP/GLP/GCP/IEC-certified contract R&D service providers, and Kiel Laboratories, Inc., a leading U.S. pharmaceutical research

Meet us at the heart of Pharma at CPHI 2024

Conscio Group is attending CPHI 2024 in Milan, Italy.

A new partnership with Reference Analytics GmbH

The Conscio Group is expanding its range of services in Austria by acquiring Reference Analytics GmbH.

Our new clinical unit in Ostrava (CZ) comes to life

It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava (CZ)

Microbiology and Batch Testing: Bridging Across Sectors

Discover LVA GmbH and EL Labs s.r.o., the only Conscio Group subsidiaries at the intersection of our Pharma and Nutrition

Ekolab and Conscio Group join forces

Ekolab joins the Conscio Group, enhancing our analytical capabilities and solidifying our position in pharmaceutical, nutrition, and technology solutions.

Pharmaceutical Offshore Outsourcing in the USA: Opportunities & Misconceptions

Dr. Jeffrey Kiel, founder and CEO of Kiel Laboratories, talks about offshore outsourcing in the USA and working with Quinta-Analytica

How can we support your organization?

Let’s talk. Whether you’re scaling operations or prepping for your next audit, we’ll help you take the next confident step.

Schedule a Consultation